ES2759281T3 - Métodos de tratamiento o prevención de afecciones respiratorias - Google Patents

Métodos de tratamiento o prevención de afecciones respiratorias Download PDF

Info

Publication number
ES2759281T3
ES2759281T3 ES13862590T ES13862590T ES2759281T3 ES 2759281 T3 ES2759281 T3 ES 2759281T3 ES 13862590 T ES13862590 T ES 13862590T ES 13862590 T ES13862590 T ES 13862590T ES 2759281 T3 ES2759281 T3 ES 2759281T3
Authority
ES
Spain
Prior art keywords
cells
stro
progeny
asthma
respiratory condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13862590T
Other languages
English (en)
Spanish (es)
Inventor
Silviu Itescu
Ravi Krishnan
Peter Ghosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mesoblast Inc
Original Assignee
Mesoblast Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mesoblast Inc filed Critical Mesoblast Inc
Application granted granted Critical
Publication of ES2759281T3 publication Critical patent/ES2759281T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0663Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ES13862590T 2012-12-12 2013-12-12 Métodos de tratamiento o prevención de afecciones respiratorias Active ES2759281T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12
PCT/AU2013/001454 WO2014089625A1 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Publications (1)

Publication Number Publication Date
ES2759281T3 true ES2759281T3 (es) 2020-05-08

Family

ID=50933587

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13862590T Active ES2759281T3 (es) 2012-12-12 2013-12-12 Métodos de tratamiento o prevención de afecciones respiratorias

Country Status (11)

Country Link
US (3) US10028979B2 (enExample)
EP (1) EP2931373B1 (enExample)
JP (5) JP6313327B2 (enExample)
KR (1) KR101748712B1 (enExample)
CN (2) CN105377274A (enExample)
AU (4) AU2013360026B2 (enExample)
CA (1) CA2893951C (enExample)
ES (1) ES2759281T3 (enExample)
IL (1) IL239309A0 (enExample)
SG (2) SG11201504352TA (enExample)
WO (1) WO2014089625A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2893951C (en) 2012-12-12 2022-05-03 Mesoblast, Inc. Methods of treating or preventing respiratory conditions
US20170296589A1 (en) * 2014-09-23 2017-10-19 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
KR20200053501A (ko) * 2017-09-15 2020-05-18 시나타 세라퓨틱스 엘티디 알레르기성 기도 질환 (aad)/ 천식을 치료하는 방법
EP4098267A4 (en) * 2020-01-30 2024-03-06 JCR Pharmaceuticals Co., Ltd. MEDICINAL COMPOSITION COMPRISING CELLS DERIVED FROM DENTAL PULP
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
ES2287447T3 (es) * 2002-02-19 2007-12-16 Medipost, Co., Ltd. Metodos de aislamiento y expansion del cultivo de celulas troncales/madre mesenquimatosas a partir de sangre del cordon umbilical, y metodo de diferenciacion de celulas troncales/madre mesenquimatosas derivadas de sangre del cordon umbilical en diversos tejidos mesenquimatosos.
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CN101506355B (zh) 2004-09-24 2012-06-27 成血管细胞系统公司 多能扩增间充质前体细胞子代(memp)及其应用
CN101248171B (zh) 2005-04-12 2015-11-25 迈索布拉斯特股份有限公司 通过组织非特异性碱性磷酸酶分离成人多潜能细胞
WO2008036374A2 (en) * 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
US9381216B2 (en) * 2007-08-06 2016-07-05 Mesoblast, Inc. Methods of generating, repairing and/or maintaining connective tissue in vivo
DK2205721T3 (en) * 2007-10-17 2016-10-24 Txcell TR1 cells mesenchymal stem cells and uses thereof
EP2324109B1 (en) * 2008-09-03 2016-10-26 Mesoblast, Inc. Expansion of haemopoietic precursors
KR101891260B1 (ko) * 2010-07-02 2018-08-24 메소블라스트, 아이엔씨. T-세포 매개된 면역 질환의 치료
US9901600B2 (en) * 2011-03-11 2018-02-27 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
AU2012262675B2 (en) 2011-06-03 2016-05-19 Mesoblast, Inc Methods of treating or preventing neurological diseases
CA2893951C (en) 2012-12-12 2022-05-03 Mesoblast, Inc. Methods of treating or preventing respiratory conditions

Also Published As

Publication number Publication date
US20200289578A1 (en) 2020-09-17
IL239309A0 (en) 2015-07-30
WO2014089625A1 (en) 2014-06-19
AU2018226514A1 (en) 2018-09-27
CA2893951A1 (en) 2014-06-19
US10688134B2 (en) 2020-06-23
HK1210077A1 (en) 2016-04-15
US10028979B2 (en) 2018-07-24
JP2020097618A (ja) 2020-06-25
AU2020202022A1 (en) 2020-04-09
AU2013360026A1 (en) 2015-07-02
US20190046575A1 (en) 2019-02-14
JP2024041904A (ja) 2024-03-27
EP2931373B1 (en) 2019-08-21
US20150306146A1 (en) 2015-10-29
JP6665218B2 (ja) 2020-03-13
CN105377274A (zh) 2016-03-02
JP2016502980A (ja) 2016-02-01
EP2931373A1 (en) 2015-10-21
KR101748712B1 (ko) 2017-06-19
SG11201504352TA (en) 2015-07-30
AU2013360026B2 (en) 2018-06-21
AU2022209219A1 (en) 2022-08-18
JP2022065132A (ja) 2022-04-26
JP2018118987A (ja) 2018-08-02
AU2022209219B2 (en) 2025-08-14
KR20150090237A (ko) 2015-08-05
JP7420844B2 (ja) 2024-01-23
EP2931373A4 (en) 2016-05-04
CN115919901A (zh) 2023-04-07
CA2893951C (en) 2022-05-03
JP6313327B2 (ja) 2018-04-18
SG10201807682PA (en) 2018-10-30
AU2018226514B2 (en) 2020-01-02

Similar Documents

Publication Publication Date Title
JP7420844B2 (ja) 呼吸器系疾患を治療又は予防する方法
ES2763316T3 (es) Procedimientos de tratamiento o prevención de enfermedades neurológicas
ES2742035T3 (es) Tratamiento de las enfermedades de la disfunción y la inflamación endotelial
AU2016247132B2 (en) Methods for treating obesity and/or metabolic syndrome
US20240024366A1 (en) Methods of treating or preventing respiratory conditions
HK1210077B (en) Methods of treating or preventing respiratory conditions
He A novel prophylactic strategy to minimize stem cell transplantation-related complications
HK1210209B (en) Treatment of diseases of endothelial dysfunction and inflammation